BRA
CMRX

Bender Robert & Associates’s Chimerix, Inc. CMRX Stock Holding History

Bender Robert & Associates’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,609
Closed -$36.9K – 49
2024
Q4 		$36.9K Buy
+10,609
New +$15K 0.01% 46
2024
Q1 		– Sell
-10,609
Closed -$10.2K – 50
2023
Q4 		$10.2K Hold
10,609
– – ﹤0.01% 50
2023
Q3 		$10.2K Hold
10,609
– – ﹤0.01% 48
2023
Q2 		$12.8K Hold
10,609
– – ﹤0.01% 50
2023
Q1 		$13.4K Buy
+10,609
New +$17.3K ﹤0.01% 55
2022
Q4 		– Sell
-10,609
Closed -$20K – 53
2022
Q3 		$20K Hold
10,609
– – 0.01% 53
2022
Q2 		$22K Buy
+10,609
New +$34.1K 0.01% 54
2021
Q2 		– Sell
-10,000
Closed -$96K – 55
2021
Q1 		$96K Buy
+10,000
New +$91.8K 0.03% 55

Other funds holding CMRX

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Bender Robert & Associates's CMRX Position: Q1 2025 in Review

Bender Robert & Associates sold out of Chimerix, Inc. (CMRX) in Q1 2025, closing a stake of 10,609 shares — an estimated $36.9K sold.

Bender Robert & Associates first reported a position in CMRX in Q1 2021 and held it in 8 quarters. The position peaked at $96K in Q1 2021. 119 funds tracked by Wall St. Rank hold CMRX as of Q1 2025.

  • Bender Robert & Associates reported no remaining Chimerix, Inc. position as of Q1 2025 after selling out during the quarter.
  • Bender Robert & Associates sold 10,609 Chimerix, Inc. shares in Q1 2025, an estimated $36.9K.
  • Bender Robert & Associates first reported a position in Chimerix, Inc. in Q1 2021 and held it in 8 quarters.
  • Bender Robert & Associates's Chimerix, Inc. position peaked at $96K in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2025.

Based on Bender Robert & Associates's 13F filing for Q1 2025, filed 18 Apr 2025.